Thought Leadership & Other Media

Webinar: Large-Scale AAV Manufacturing: The Road from Concept to Ready-to-Use Platform

Thought Leadership Cell & Gene Therapy

It's with tremendous excitement that we announce the webinar and live Q&A session, titled “Large-Scale AAV Manufacturing: The Road from Concept to Ready-to-Use Platform” will be held Wednesday, May 26th at 8:00 AM PDT / 5:00 pm CEST.  This webinar will be co-presented by Margherita Neri, Upstream Vector Process Development Manager, AGC Biologics, and Claire Wartel, Director of Quality and Compliance, Polyplus-Transfection.

AGC Biologics is Attending ASGCT May 11-14, 2021 and Presenting Our Scalable LVV Production Process and Large-Scale AAV Manufacturing Development Data

Events Cell & Gene Therapy

We're pleased to announce that we will be attending ASGCT this year, running virtually from May 11 through the 14. Be sure to save some time to meet with our team, check out our two abstracts and presentations on lentiviral vector (LVV) and adeno-associated virus (AAV) – both of which we're thrilled to share with you and the community.  

Follow Us
Join us on LinkedIn Follow us on Twitter